Cargando…
The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
β-thalassemia, a disease that results from defects in β-globin synthesis, leads to an imbalance of β- and α-globin chains and an excess of α chains. Defective erythroid maturation, ineffective erythropoiesis, and shortened red blood cell survival are commonly observed in most β-thalassemia patients....
Autores principales: | Rattananon, Parin, Anurathapan, Usanarat, Bhukhai, Kanit, Hongeng, Suradej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517149/ https://www.ncbi.nlm.nih.gov/pubmed/34658870 http://dx.doi.org/10.3389/fphar.2021.730873 |
Ejemplares similares
-
Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models
por: Sawaisorn, Piamsiri, et al.
Publicado: (2023) -
In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes
por: Kaewsakulthong, Woratree, et al.
Publicado: (2022) -
Enhancing Erythropoiesis by a Phytoestrogen Diarylheptanoid from Curcuma comosa
por: Bhukhai, Kanit, et al.
Publicado: (2022) -
Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major
por: Thanuthanakhun, Naruchit, et al.
Publicado: (2017) -
No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease
por: Lertthammakiat, Surapong, et al.
Publicado: (2020)